FDA Clears Cheetah Reliant for Cardiac Monitoring
The FDA cleared for marketing the Reliant, a portable cardiac output monitor that provides a noninvasive window to cardiac and hemodynamic function.
The monitor is powered by Cheetah’s BIOREACTANCE Technology, which has been reportedly used with more than 1,000 patients in various clinical settings for hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing. Traditional bioimpedance analyzes changes in voltage of electrical currents traversing the patient’s chest, while BIOREACTANCE also analyzes frequency-related effects. NICOM’s hybrid analysis helps deal with electrical noise interference, patient movement, respiration and electrode misplacement. As a result, NICOM is said to enable an accurate and responsive measurement of cardiac function and hemodynamic status not available with other modalities.